Ventria Bioscience and the Controversy over Plant-Made Medicines
Sinforosa
Business and Society - BUS 475
Professor Filomena
May 17, 2011
1.-Describe the problem facing Scott Deeter and Ventria.
Deeter came to Ventria in April 2002. He was appointed as Ventria’s CEO because of his good reputation as a businessman. As CEO he helped Dr. Raymond Rodriguez sort through several projects that Ventria was working on at the time. His concept of the business was to focus on one or two projects to make Ventria a profitable business.
2.-Describe the relevant stakeholders and for each, state its interests and sources of power.
Rice farmers, are more than 2000 businesses owned by families and have been in the business since 1997. Rice is theirs lives and place an important role in California’s Economy.
The rice they produce is exported to several countries which include Japan, Taiwan, Korea, and Turkey.
Rice mills owned by companies provide capital for the rice operation. Rice mills such as ADM, Far West Rice, Pacific International, and Sun West have invested in rice through the years and are big organizations that depend on its quality. These companies have created jobs and are committed to distributing the rice produced by the California Rice Farmers to the US and the world.
Both have invested time and money. California has highly refined technology which can compete with the international market, however only the 12% of rice production was exported in 2003.
3.-Describe the options that might emerge from a dialogue between Ventria and its relevant stakeholders.
Ventria’s rice production was a secret before 2001. It was exposed to the public by a Greenpeace researcher.
Some members of the CRC were ok with Ventria because they promised to farm in especially covered fields, use sealed trucks and high tech equipment to eliminate the contact with the air.
References: Pamer, M. (2004, July). Prescription Rice Message posted to http://ecologycenter.org/terrain/issues/summer-2004/prescription-rice/ California Rice Commission statical Report, May 1, 2005 Lawrence, A. T. (2008). Business and Society. In B. Gordon (Ed.), Ventria Bioscience and the Controversy over Plant-Made Medicines (Vol. Thirteenth Edition, p. 500). New York, NY: MMcGraw-Hill Irwin. .